Skip to main content

ovarian cancer

Research Reports
06/05/2023
Emma L. Barber, MD, and colleagues investigate current and real-world practice patterns for patients receiving maintenance therapy for recurrent ovarian cancer after second-line chemotherapy.
Emma L. Barber, MD, and colleagues investigate current and real-world practice patterns for patients receiving maintenance therapy for recurrent ovarian cancer after second-line chemotherapy.
Emma L. Barber, MD, and...
06/05/2023
Journal of Clinical Pathways
News
07/06/2022
Whether ostomy worsens survival outcomes is a topic of controversy. Therefore, a research team from China investigated patient outcomes after undergoing ostomy after bowel resections.
Whether ostomy worsens survival outcomes is a topic of controversy. Therefore, a research team from China investigated patient outcomes after undergoing ostomy after bowel resections.
Whether ostomy worsens survival...
07/06/2022
Wound Care
David O'Malley, MD, Ohio State University Comprehensive Cancer Center
Videos
07/04/2021
David O'Malley, MD, highlights promising results from a subgroup analysis of the effect of platinum sensitivity on the efficacy of rucaparib vs chemo for BRCA–positive, advanced, relapsed ovarian carcinoma.
David O'Malley, MD, highlights promising results from a subgroup analysis of the effect of platinum sensitivity on the efficacy of rucaparib vs chemo for BRCA–positive, advanced, relapsed ovarian carcinoma.
David O'Malley, MD, highlights...
07/04/2021
Oncology
HRQoL in Newly Diagnosed Ovarian Cancer Treated With Veliparib
Videos
11/28/2020
Journal of Clinical Pathways
Overview of the Updated NCCN Guidelines on Ovarian Cancer
Special Report
06/17/2020
While ovarian cancer is the second most common gynecologic cancer in the United States, behind uterine cancer,1 it is the top gynecologic cancer in mortality.2 In 2020, an estimated 21,750 new cases of ovarian cancer...
While ovarian cancer is the second most common gynecologic cancer in the United States, behind uterine cancer,1 it is the top gynecologic cancer in mortality.2 In 2020, an estimated 21,750 new cases of ovarian cancer...
While...
06/17/2020
Journal of Clinical Pathways
News
06/09/2020
Olaparib improves survival outcomes for patients with germline BRCA-mutated, platinum-sensitive, relapsed ovarian cancer who received at least two prior lines of platinum-based chemotherapy, according to a...
Olaparib improves survival outcomes for patients with germline BRCA-mutated, platinum-sensitive, relapsed ovarian cancer who received at least two prior lines of platinum-based chemotherapy, according to a...
...
06/09/2020
Journal of Clinical Pathways
News
06/03/2020
Pembrolizumab monotherapy continues to show modest antitumor activity in patients with recurrent advanced ovarian cancer, according to updated results of the KEYNOTE-100 study presented at the American Society of...
Pembrolizumab monotherapy continues to show modest antitumor activity in patients with recurrent advanced ovarian cancer, according to updated results of the KEYNOTE-100 study presented at the American Society of...
...
06/03/2020
Journal of Clinical Pathways